HER2 Support Group Forums - View Single Post - Celltrion and iProgen Biotech announce partnership for development of novel ADCs

News · 04-07-2019, 10:12 PM

On April 8, Celltrion and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 and CD20.

More...

04-07-2019, 10:12 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,952	Celltrion and iProgen Biotech announce partnership for development of novel ADCs On April 8, Celltrion and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 and CD20. More...